Research in the Gaucher group provides evolutionary insights into why humans develop gout.
Jeff Skolnick awarded for fostering excellence in scientific research
A new study found evidence that assessing the route to cancer on a case-by-case basis might make more sense than basing a patient’s cancer treatment on commonly disrupted genes and pathways.
Exploiting the use of DNA single- and double-strand breaking forms of the I-SceI endonuclease to stimulate homologous recombination and gene targeting in budding yeast and in human cells
